Sfoglia per Titolo
Risk measurements in decision making with emotional arousal
2014 Uberti, P; Maggi, M; Lucarelli, C
Risk measures and Pareto tails
2012 Fiori, A; ROSAZZA GIANIN, E; Spasova, A
Risk Measures and Progressive Enlargement of Filtration: A BSDE Approach
2020 Calvia, A; Rosazza Gianin, E
Risk Measures Based on Benchmark Loss Distributions
2020 Bignozzi, V; Burzoni, M; Munari, C
Risk Measures on P(R) and Value At Risk with Probability/Loss function
2012 Frittelli, M; Maggis, M; Peri, I
Risk measures via g-expectations
2006 ROSAZZA GIANIN, E
Risk measures with the CxLS property
2016 Delbaen, F; Bellini, F; Bignozzi, V; Ziegel, J
Risk Minimisation Measures in The EU: Communication, Implementation Challenges and Methods for Impact Assessment - prerecorded presentation [Session: Risk Communication in EU, US and Japan: Goals and Objective of Various Tools Including Labelling, part 1]
2015 Mazzaglia, G
Risk Minimization
2018 Mazzaglia, G; Straus, S
Risk Models for predicting stroke and Upper Gastrointestinal Complications in NSAID Users: the SOS Project
2012 Romio, S; Valkhoff, V; Schuemie, M; Schade, R; Garbe, E; Varas Lorenzo, C; Lucchi, S; Herings, R; Arfè, A; Schink, T; Neubronner, J; Thiessard, F; Straatman, H; Villa, M; Nicotra, F; Sturkenboom, M; Steyerberg, E
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome)
2021 Bettiol, A; Sinico, R; Schiavon, F; Monti, S; Bozzolo, E; Franceschini, F; Govoni, M; Lunardi, C; Guida, G; Lopalco, G; Paolazzi, G; Vacca, A; Gregorini, G; Leccese, P; Piga, M; Conti, F; Fraticelli, P; Quartuccio, L; Alberici, F; Salvarani, C; Bettio, S; Negrini, S; Selmi, C; Sciascia, S; Moroni, G; Colla, L; Manno, C; Urban, M; Vannacci, A; Pozzi, M; Fabbrini, P; Polti, S; Felicetti, M; Marchi, M; Padoan, R; Delvino, P; Caporali, R; Montecucco, C; Dagna, L; Cariddi, A; Toniati, P; Tamanini, S; Furini, F; Bortoluzzi, A; Tinazzi, E; Delfino, L; Badiu, I; Rolla, G; Venerito, V; Iannone, F; Berti, A; Bortolotti, R; Racanelli, V; Jeannin, G; Padula, A; Cauli, A; Priori, R; Gabrielli, A; Bond, M; Tedesco, M; Pazzola, G; Tomietto, P; Pellecchio, M; Marvisi, C; Maritati, F; Palmisano, A; Dejaco, C; Willeit, J; Kiechl, S; Olivotto, I; Willeit, P; Prisco, D; Vaglio, A; Emmi, G
Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project
2018 Masclee, G; Straatman, H; Arfè, A; Castellsague, J; Garbe, E; Herings, R; Kollhorst, B; Lucchi, S; Perez-Gutthann, S; Romio, S; Schade, R; Schink, T; Schuemie, M; Scotti, L; Varas-Lorenzo, C; Valkhoff, V; Villa, M; Sturkenboom, M
Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer
2013 Borroni, R; Carugno, A; Rivetti, N; Arbustini, E; Brazzelli, V
Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)
2004 Mancia, G; Keltai, M; Erdine, S; Hewkin, A; Kupfer, S; Pepine, C
Risk of adverse events in gastrointestinal endoscopy: Zero-inflated Poisson regression mixture model for count data and multinomial logit model for the type of event
2021 Gemma, M; Pennoni, F; Tritto, R; Agostoni, M
Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
2022 Orsi, E; Solini, A; Bonora, E; Vitale, M; Garofolo, M; Fondelli, C; Trevisan, R; Vedovato, M; Cavalot, F; Laviola, L; Morano, S; Pugliese, G
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study
2015 Herrera, L; Leal, I; Lapi, F; Schuemie, M; Arcoraci, V; Cipriani, F; Sessa, E; Vaccheri, A; Piccinni, C; Staniscia, T; Vestri, A; Di Bari, M; Corrao, G; Zambon, A; Gregori, D; Carle, F; Sturkenboom, M; Mazzaglia, G; Trifiro, G
Risk of cardiac valve fibrosis and other fibroses with dopamine agonist use in Parkinson's disease
2010 Trifiro, G; Mokhles, M; Dieleman, J; van Soest, E; Mazzaglia, G; Herings, R; Brusselle, G; Colao, A; Haverkamp, W; Schade, R; Van Camp, G; Zanettini, R; de Luise, C; Ross, D; Sturkenboom, M
Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinson's Disease and Hyperprolactinaemia A Multi-Country, Nested Case-Control Study
2012 Trifiro, G; Mokhles, M; Dieleman, J; van Soest, E; Verhamme, K; Mazzaglia, G; Herings, R; de Luise, C; Ross, D; Brusselle, G; Colao, A; Haverkamp, W; Schade, R; van Camp, G; Zanettini, R; Sturkenboom, M
Risk of Cardiac Valve Regurgitation with Dopamine Agonist Use in Parkinson's Disease and Hyperprolactinemia
2010 Trifiro', G; Mokhles, M; Dieleman, J; van Soest, E; Mazzaglia, G; Herings, R; de Luise, C; Ross, D; Brusselle, G; Colao, A; Haverkamp, W; Schade, R; van Camp, G; Zanettini, R; Sturkenboom, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile